Interpretation of LHCb Hidden-Charm Pentaquarks within the Compact Diquark Model

por Ali, Ahmed, Ahmed, Ishtiaq, Aslam, M. Jamil, Parkhomenko, Alexander, Rehman, Abdur
Publicado 2021

A New Look at the $Y$ Tetraquarks and $\Omega_c$ Baryons in the Diquark Model

por Ali, Ahmed, Maiani, Luciano, Borisov, Anatoly V., Ahmed, Ishtiaq, Jamil Aslam, M., Parkhomenko, Alexander Ya., Polosa, Antonio D., Rehman, Abdur
Publicado 2017

New Look at Hidden Charm Tetra and Pentaquark States

por Ali, Ahmed, Maiani, Luciano, Borisov, Anatoly V, Ahmed, Ishtiaq, Aslam, M Jamil, Parkhomenko, Alexander Ya, Polosa, Antonio D, Rehman, Abdur
Publicado 2018

β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study

por Sorbets, Emmanuel, Steg, Philippe Gabriel, Young, Robin, Danchin, Nicolas, Greenlaw, Nicola, Ford, Ian, Tendera, Michal, Ferrari, Roberto, Merkely, Bela, Parkhomenko, Alexander, Reid, Christopher, Tardif, Jean-Claude, Fox, Kim M
Publicado 2019

Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation

por Hijazi, Ziad, Granger, Christopher B., Hohnloser, Stefan H., Westerbergh, Johan, Lindbäck, Johan, Alexander, John H., Keltai, Matyas, Parkhomenko, Alexander, López-Sendón, José L., Lopes, Renato D., Siegbahn, Agneta, Wallentin, Lars
Publicado 2020

Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial

por Welsh, Robert C., Dehghani, Payam, Lopes, Renato, Wojdyla, Daniel M, Aronson, Ronald, Granger, Christopher B, Windecker, Stephan, Vora, Amit N, Vinereanu, Dragos, Halvorsen, Sigrun, Parkhomenko, Alexander, Mehran, Roxana, Alexander, John H, Goodman, Shaun
Publicado 2022

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency(†)

por Ponikowski, Piotr, van Veldhuisen, Dirk J., Comin-Colet, Josep, Ertl, Georg, Komajda, Michel, Mareev, Viacheslav, McDonagh, Theresa, Parkhomenko, Alexander, Tavazzi, Luigi, Levesque, Victoria, Mori, Claudio, Roubert, Bernard, Filippatos, Gerasimos, Ruschitzka, Frank, Anker, Stefan D.
Publicado 2015

New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GAR...

por Goto, Shinichi, Goto, Shinya, Pieper, Karen S, Bassand, Jean-Pierre, Camm, Alan John, Fitzmaurice, David A, Goldhaber, Samuel Z, Haas, Sylvia, Parkhomenko, Alexander, Oto, Ali, Misselwitz, Frank, Turpie, Alexander G G, Verheugt, Freek W A, Fox, Keith A A, Gersh, Bernard J, Kakkar, Ajay K
Publicado 2019

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OU...

por Tuñón, José, Steg, Philippe Gabriel, Bhatt, Deepak L, Bittner, Vera A, Díaz, Rafael, Goodman, Shaun G, Jukema, J Wouter, Kim, Yong-Un, Li, Qian H, Mueller, Christian, Parkhomenko, Alexander, Pordy, Robert, Sritara, Piyamitr, Szarek, Michael, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G
Publicado 2020

Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction

por Magnani, Giulia, Ardissino, Diego, Im, KyungAh, Budaj, Andrzej, Storey, Robert F., Steg, P. Gabriel, Bhatt, Deepak L., Cohen, Marc, Oude Ophius, Ton, Goudev, Assen, Parkhomenko, Alexander, Kamensky, Gabriel, Angiolillo, Dominick J., López‐Sendón, José, Johanson, Per, Braunwald, Eugene, Sabatine, Marc S., Bonaca, Marc P.
Publicado 2021

Renal Effects of Levosimendan: A Consensus Report

por Yilmaz, Mehmet B., Grossini, Elena, Silva Cardoso, José C., Édes, István, Fedele, Francesco, Pollesello, Piero, Kivikko, Matti, Harjola, Veli-Pekka, Hasslacher, Julia, Mebazaa, Alexandre, Morelli, Andrea, le Noble, Jos, Oldner, Anders, Oulego Erroz, Ignacio, Parissis, John T., Parkhomenko, Alexander, Poelzl, Gerhard, Rehberg, Sebastian, Ricksten, Sven-Erik, Rodríguez Fernández, Luís M., Salmenperä, Markku, Singer, Mervyn, Treskatsch, Sascha, Vrtovec, Bojan, Wikström, Gerhard
Publicado 2013

Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?

por Pollesello, Piero, Ben Gal, Tuvia, Bettex, Dominique, Cerny, Vladimir, Comin-Colet, Josep, Eremenko, Alexandr A., Farmakis, Dimitrios, Fedele, Francesco, Fonseca, Cândida, Harjola, Veli-Pekka, Herpain, Antoine, Heringlake, Matthias, Heunks, Leo, Husebye, Trygve, Ivancan, Visnja, Karason, Kristjan, Kaul, Sundeep, Kubica, Jacek, Mebazaa, Alexandre, Mølgaard, Henning, Parissis, John, Parkhomenko, Alexander, Põder, Pentti, Pölzl, Gerhard, Vrtovec, Bojan, Yilmaz, Mehmet B., Papp, Zoltan
Publicado 2019

Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54

por Bonaca, Marc P., Wiviott, Stephen D., Morrow, David A., Steg, P. Gabriel, Hamm, Christian, Bhatt, Deepak L., Storey, Robert F., Cohen, Marc, Kuder, Julia, Im, KyungAh, Magnani, Giulia, Budaj, Andrzej, Nicolau, José C., Parkhomenko, Alexander, López‐Sendón, José, Dellborg, Mikael, Diaz, Rafael, Van de Werf, Frans, Corbalán, Ramón, Goudev, Assen, Jensen, Eva C., Johanson, Per, Braunwald, Eugene, Sabatine, Marc S.
Publicado 2018

Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

por Steg, Philippe Gabriel, Szarek, Michael, Bhatt, Deepak L., Bittner, Vera A., Brégeault, Marie-France, Dalby, Anthony J., Diaz, Rafael, Edelberg, Jay M., Goodman, Shaun G., Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W., Moryusef, Angèle, Ostadal, Petr, Parkhomenko, Alexander, Pordy, Robert, Roe, Matthew T., Tricoci, Pierluigi, Vogel, Robert, White, Harvey D., Zeiher, Andreas M., Schwartz, Gregory G.
Publicado 2019

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participant...

por Bosch, Jackie, Lonn, Eva M, Jung, Hyejung, Zhu, Jun, Liu, Lisheng, Lopez-Jaramillo, Patricio, Pais, Prem, Xavier, Denis, Diaz, Rafael, Dagenais, Gilles, Dans, Antonio, Avezum, Alvaro, Piegas, Leopoldo S, Parkhomenko, Alexander, Keltai, Kati, Keltai, Matyas, Sliwa, Karen, Held, Claus, Peters, Ronald J G, Lewis, Basil S, Jansky, Petr, Yusoff, Khalid, Khunti, Kamlesh, Toff, William D, Reid, Christopher M, Varigos, John, Joseph, Philip, Leiter, Lawrence A, Yusuf, Salim
Publicado 2021

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

por Vallejo-Vaz, Antonio J., Bray, Sarah, Villa, Guillermo, Brandts, Julia, Kiru, Gaia, Murphy, Jennifer, Banach, Maciej, De Servi, Stefano, Gaita, Dan, Gouni-Berthold, Ioanna, Kees Hovingh, G., Jozwiak, Jacek J., Jukema, J. Wouter, Gabor Kiss, Robert, Kownator, Serge, Iversen, Helle K., Maher, Vincent, Masana, Luis, Parkhomenko, Alexander, Peeters, André, Clifford, Piers, Raslova, Katarina, Siostrzonek, Peter, Romeo, Stefano, Tousoulis, Dimitrios, Vlachopoulos, Charalambos, Vrablik, Michal, Catapano, Alberico L., Poulter, Neil R., Ray, Kausik K.
Publicado 2022

The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study

por Jankowska, Ewa A, Kirwan, Bridget-Anne, Kosiborod, Mikhail, Butler, Javed, Anker, Stefan D, McDonagh, Theresa, Dorobantu, Maria, Drozdz, Jarosław, Filippatos, Gerasimos, Keren, Andre, Khintibidze, Irakli, Kragten, Hans, Martinez, Felipe A, Metra, Marco, Milicic, Davor, Nicolau, José C, Ohlsson, Marcus, Parkhomenko, Alexander, Pascual-Figal, Domingo A, Ruschitzka, Frank, Sim, David, Skouri, Hadi, van der Meer, Peter, Lewis, Basil S, Comin-Colet, Josep, von Haehling, Stephan, Cohen-Solal, Alain, Danchin, Nicolas, Doehner, Wolfram, Dargie, Henry J, Motro, Michael, Friede, Tim, Fabien, Vincent, Dorigotti, Fabio, Pocock, Stuart, Ponikowski, Piotr
Publicado 2011

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

por Papp, Zoltán, Agostoni, Piergiuseppe, Alvarez, Julian, Bettex, Dominique, Bouchez, Stefan, Brito, Dulce, Černý, Vladimir, Comin-Colet, Josep, Crespo-Leiro, Marisa G., Delgado, Juan F., Édes, István, Eremenko, Alexander A., Farmakis, Dimitrios, Fedele, Francesco, Fonseca, Cândida, Fruhwald, Sonja, Girardis, Massimo, Guarracino, Fabio, Harjola, Veli-Pekka, Heringlake, Matthias, Herpain, Antoine, Heunks, Leo M. A., Husebye, Tryggve, Ivancan, Višnja, Karason, Kristjan, Kaul, Sundeep, Kivikko, Matti, Kubica, Janek, Masip, Josep, Matskeplishvili, Simon, Mebazaa, Alexandre, Nieminen, Markku S., Oliva, Fabrizio, Papp, Julius G., Parissis, John, Parkhomenko, Alexander, Põder, Pentti, Pölzl, Gerhard, Reinecke, Alexander, Ricksten, Sven-Erik, Riha, Hynek, Rudiger, Alain, Sarapohja, Toni, Schwinger, Robert H. G., Toller, Wolfgang, Tritapepe, Luigi, Tschöpe, Carsten, Wikström, Gerhard, von Lewinski, Dirk, Vrtovec, Bojan, Pollesello, Piero
Publicado 2020

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

por Papp, Zoltán, Agostoni, Piergiuseppe, Alvarez, Julian, Bettex, Dominique, Bouchez, Stefan, Brito, Dulce, Černý, Vladimir, Comin-Colet, Josep, Crespo-Leiro, Marisa G, Delgado, Juan F, Édes, Istvan, Eremenko, Alexander A, Farmakis, Dimitrios, Fedele, Francesco, Fonseca, Cândida, Fruhwald, Sonja, Girardis, Massimo, Guarracino, Fabio, Harjola, Veli-Pekka, Heringlake, Matthias, Herpain, Antoine, Heunks, Leo MA, Husebye, Tryggve, Ivancan, Višnja, Karason, Kristjan, Kaul, Sundeep, Kivikko, Matti, Kubica, Janek, Masip, Josep, Matskeplishvili, Simon, Mebazaa, Alexandre, Nieminen, Markku S, Oliva, Fabrizio, Papp, Julius-Gyula, Parissis, John, Parkhomenko, Alexander, Põder, Pentti, Pölzl, Gerhard, Reinecke, Alexander, Ricksten, Sven-Erik, Riha, Hynek, Rudiger, Alain, Sarapohja, Toni, Schwinger, Robert HG, Toller, Wolfgang, Tritapepe, Luigi, Tschöpe, Carsten, Wikström, Gerhard, von Lewinski, Dirk, Vrtovec, Bojan, Pollesello, Piero
Publicado 2020

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials

por Teerlink, John R., Diaz, Rafael, Felker, G. Michael, McMurray, John J.V., Metra, Marco, Solomon, Scott D., Adams, Kirkwood F., Anand, Inder, Arias‐Mendoza, Alexandra, Biering‐Sørensen, Tor, Böhm, Michael, Bonderman, Diana, Cleland, John G.F., Corbalan, Ramon, Crespo‐Leiro, Maria G., Dahlström, Ulf, Echeverria Correa, Luis E., Fang, James C., Filippatos, Gerasimos, Fonseca, Cândida, Goncalvesova, Eva, Goudev, Assen R., Howlett, Jonathan G., Lanfear, David E., Lund, Mayanna, Macdonald, Peter, Mareev, Vyacheslav, Momomura, Shin‐ichi, O'Meara, Eileen, Parkhomenko, Alexander, Ponikowski, Piotr, Ramires, Felix J.A., Serpytis, Pranas, Sliwa, Karen, Spinar, Jindrich, Suter, Thomas M., Tomcsanyi, Janos, Vandekerckhove, Hans, Vinereanu, Dragos, Voors, Adriaan A., Yilmaz, Mehmet B., Zannad, Faiez, Sharpsten, Lucie, Legg, Jason C., Abbasi, Siddique A., Varin, Claire, Malik, Fady I., Kurtz, Christopher E.
Publicado 2020